CannTrust Holdings Inc. produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner. The company has a partnership with Gold Coast University Hospital. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone64-7872-2300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$15.96 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
CannTrust (OTCMKTS:CNTTF) Frequently Asked Questions
What is CannTrust's stock symbol?
CannTrust trades on the OTCMKTS under the ticker symbol "CNTTF."
What is the consensus analysts' recommendation for CannTrust?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CannTrust in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CannTrust.
Has CannTrust been receiving favorable news coverage?
Headlines about CNTTF stock have been trending positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CannTrust earned a media sentiment score of 2.6 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future.
Who are some of CannTrust's key competitors?
Some companies that are related to CannTrust include FibroGen (FGEN), Agios Pharmaceuticals (AGIO), Amicus Therapeutics (FOLD), Biohaven Pharmaceutical (BHVN), Mirati Therapeutics (MRTX), Reata Pharmaceuticals (RETA), Arena Pharmaceuticals (ARNA), Intercept Pharmaceuticals (ICPT), The Medicines (MDCO), Amneal Pharmaceuticals (AMRX), Uniqure (QURE), PTC Therapeutics (PTCT), Myokardia (MYOK), Emergent Biosolutions (EBS) and Ligand Pharmaceuticals (LGND).
What other stocks do shareholders of CannTrust own?
Who are CannTrust's key executives?
CannTrust's management team includes the folowing people:
- Mr. Eric Paul, Co-Founder & Chairman (Age 78)
- Mr. Brad Rogers, Pres (Age 49)
- Mr. Ian Abramowitz, Chief Financial Officer (Age 64)
- Mr. Peter Ralph Aceto, Chief Exec. Officer
- Mr. Stanley Abramowitz, Sec. (Age 59)
How do I buy shares of CannTrust?
Shares of CNTTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How big of a company is CannTrust?
CannTrust has a market capitalization of $0.00 and generates $15.96 million in revenue each year.
What is CannTrust's official website?
How can I contact CannTrust?
CannTrust's mailing address is 3280 Langstaff Road Building 1, Vaughan A6, L4K 5B6. The company can be reached via phone at 64-7872-2300 or via email at [email protected]
MarketBeat Community Rating for CannTrust (OTCMKTS CNTTF)
MarketBeat's community ratings are surveys of what our community members think about CannTrust and other stocks. Vote "Outperform" if you believe CNTTF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNTTF will underperform the S&P 500 over the long term. You may vote once every thirty days.
